KPRX insider transaction filings
KIORA PHARMACEUTICALS INC — 25 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen KPRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Tosca Melissa — CFO | Tax withholding (F): 911 @ $2.66 | EDGAR |
| 2026-07-02 | 4 | Strem Brian M. — President and CEO, Director | Tax withholding (F): 1,869 @ $2.66 | EDGAR |
| 2026-06-12 | 4 | Parsons Erin — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Stengone Carmine N. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Shapiro Aron — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Hollander David — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Walters-Hoffert Lisa — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | TYLE PRAVEEN — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Tosca Melissa — CFO | Tax withholding (F): 929 @ $1.95 | EDGAR |
| 2026-04-02 | 4 | Daniels Eric Joseph — Chief Development Officer | Tax withholding (F): 929 @ $1.95 | EDGAR |
| 2026-04-02 | 4 | Strem Brian M. — President and CEO, Director | Tax withholding (F): 1,906 @ $1.95 | EDGAR |
| 2026-03-10 | 4 | Daniels Eric Joseph — Chief Development Officer | Grant/award (A): 6,533 @ $0 · Grant/award (A): 13,067 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Strem Brian M. — President and CEO, Director | Grant/award (A): 16,733 @ $0 · Grant/award (A): 33,467 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Tosca Melissa — CFO | Grant/award (A): 6,533 @ $0 · Grant/award (A): 13,067 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Daniels Eric Joseph — Chief Development Officer | Tax withholding (F): 238 @ $2.02 | EDGAR |
| 2026-03-06 | 4 | Strem Brian M. — President and CEO, Director | Tax withholding (F): 238 @ $2.02 | EDGAR |
| 2025-04-02 | 4 | Tosca Melissa — CFO | Grant/award (A): 7,772 @ $0 · Grant/award (A): 15,543 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Daniels Eric Joseph — Chief Development Officer | Grant/award (A): 7,772 @ $0 · Grant/award (A): 15,543 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Strem Brian M. — President and CEO, Director | Grant/award (A): 15,941 @ $0 · Grant/award (A): 31,883 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Shapiro Aron — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Parsons Erin — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Hollander David — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Stengone Carmine N. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Walters-Hoffert Lisa — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | TYLE PRAVEEN — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — KIORA PHARMACEUTICALS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-13 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KPRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →